Getting bacteria to do a plant’s job
Researchers engineer microbes for low-cost production of precursor of anticancer drug Taxol and other pharmaceuticals.
An unexpected twist in cancer metabolism
A cancer-cell quirk could be exploited to develop new drugs that starve tumors.
From sponges, a potential cancer drug
MIT chemists have synthesized a family of natural compounds that have shown promise in killing tumor cells.
A pharmacy on the back of a cell
Drugs encapsulated in new MIT nanoparticles can hitch a ride to tumors on the surface of immune-system cells.
Lunch with a Laureate: Robert Horvitz
Presented by the MIT Museum and the Cambridge Science Festival
Super-sizing a cancer drug minimizes side effects
Researchers design a new version of cisplatin that spares the kidneys, letting doctors use higher doses.
Annual Technology Day Report 2010
From Technology Day 2010 Against the Grain: The Power of Thinking Differently
Imaging fish on the fly
New MIT technology allows high-speed study of zebrafish larvae, often used to model human diseases.
Postdoctoral associate wins cancer fellowship
Heller, of chemical engineering, named among 18 fellows
MIT’s Koch Institute in strategic partnership with Ortho-McNeil-Janssen Pharmaceuticals
Organizations will collaborate in multiple areas of oncology research and technology development.
Researchers seek to put the squeeze on cancer
Cell contractions may be key to initiating new blood-vessel growth near tumors.
Explained: Directed evolution
Speeding up protein evolution in the lab can yield useful molecules that nature never intended.
Tackling cancer on a new front
New program at MIT’s Koch Institute targets the growing cancer problem in India.
Why cancer drugs lose their power
MIT biologists show how tumors can become resistant to the commonly used chemotherapy drug cisplatin.